RESUMO
In vitro techniques are essential in elucidating biochemical mechanisms and for screening a wide range of possible bioactive candidates. The number of papers published reporting in vitro bioavailability and bioactivity of flavonoids and flavonoid-rich plant extracts is numerous and still increasing. However, even with the present knowledge on the bioavailability and metabolism of flavonoids after oral ingestion, certain inaccuracies still persist in the literature, such as the use of plant extracts to study bioactivity towards vascular cells. There is therefore a need to revisit, even question, these approaches in terms of their biological relevance. In this review, the bioavailability of flavonoid glycosides, the use of cell models for intestinal absorption and the use of flavonoid aglycones and flavonoid-rich plant extracts in in vitro bioactivity studies will be discussed. Here, we focus on the limitations of current in vitro systems and revisit the validity of some in vitro approaches, and not on the detailed mechanism of flavonoid absorption and bioactivity. Based on the results in the review, there is an apparent need for stricter guidelines on publishing data on in vitro data relating to the bioavailability and bioactivity of flavonoids and flavonoid-rich plant extracts.
Assuntos
Absorção Fisiológica , Suplementos Nutricionais , Flavonoides/metabolismo , Absorção Intestinal , Extratos Vegetais/metabolismo , Animais , Pesquisa Biomédica/educação , Pesquisa Biomédica/métodos , Pesquisa Biomédica/normas , Pesquisa Biomédica/tendências , Congressos como Assunto , Glicosídeos/metabolismo , Guias como Assunto , Humanos , Técnicas In Vitro/normas , Técnicas In Vitro/tendências , Ciências da Nutrição/educação , Ciências da Nutrição/métodos , Ciências da Nutrição/normas , Ciências da Nutrição/tendências , Publicações Periódicas como Assunto/normas , Sociedades CientíficasRESUMO
No disponible
Assuntos
Animais , Camundongos , Diabetes Mellitus/sangue , Diabetes Mellitus/metabolismo , Ilhotas Pancreáticas/anormalidades , Ilhotas Pancreáticas/lesões , Técnicas In Vitro/instrumentação , Técnicas In Vitro/métodos , International Research Information System , Óleo de Palmeira/análise , Diabetes Mellitus/genética , Diabetes Mellitus/patologia , Ilhotas Pancreáticas/metabolismo , Ilhotas Pancreáticas/patologia , Técnicas In Vitro/normas , Técnicas In Vitro , Óleo de Palmeira/prevenção & controle , Espanha/etnologiaRESUMO
Developing effective anticancer treatments is a particular challenge, as agents must contend with not only the target cellular biology, but also with the complex tumor microenvironment. Here we discuss various in vitro strategies that have sought to address this issue, with a particular focus on new methodologies that utilize clinical samples in basic research and their application in gene therapy and virotherapy.
Assuntos
Terapia Genética , Neoplasias/genética , Neoplasias/terapia , Animais , Técnicas de Cultura de Células , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos/métodos , Técnicas de Transferência de Genes , Terapia Genética/métodos , Vetores Genéticos/genética , Humanos , Técnicas In Vitro/métodos , Técnicas In Vitro/normas , Esferoides Celulares , Transdução Genética , Pesquisa Translacional Biomédica , Células Tumorais CultivadasRESUMO
There is an urgent need for the development of alternative methods to replace animal testing for the prediction of repeat dose chemical toxicity. To address this need, the European Commission and Cosmetics Europe have jointly funded a research program for 'Safety Evaluation Ultimately Replacing Animal Testing.' The goal of this program was the development of in vitro cellular systems and associated computational capabilities for the prediction of hepatic, cardiac, renal, neuronal, muscle, and skin toxicities. An essential component of this effort is the choice of appropriate reference compounds that can be used in the development and validation of assays. In this review, we focus on the selection of reference compounds for liver pathologies in the broad categories of cytotoxicity and lipid disorders. Mitochondrial impairment, oxidative stress, and apoptosis are considered under the category of cytotoxicity, while steatosis, cholestasis, and phospholipidosis are considered under the category of lipid dysregulation. We focused on four compound classes capable of initiating such events, i.e., chemically reactive compounds, compounds with specific cellular targets, compounds that modulate lipid regulatory networks, and compounds that disrupt the plasma membrane. We describe the molecular mechanisms of these compounds and the cellular response networks which they elicit. This information will be helpful to both improve our understanding of mode of action and help in the selection of appropriate mechanistic biomarkers, allowing us to progress the development of animal-free models with improved predictivity to the human situation.